Patients' perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS ©) to monitor and manage chemotherapy related toxicity

L. McCann, Roma Maguire, M. Miller, N. Kearney

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Chemotherapy forms a core component of treatment for the majority patients with cancer. Recent changes in cancer services mean patients frequently receive such treatment as outpatients and are often required to manage side effects at home without direct support from oncology health professionals. Information technology continues to develop to support patients in the community; this study evaluated the impact of a mobile phone-based advanced symptom management system (ASyMS ©) on chemotherapy related toxicity in patients with lung, breast or colorectal cancer. One hundred and twelve patients were randomized from seven clinical sites across the UK; 56 patients used the mobile phone to record their symptoms, sending their reports directly to the nurses at their clinical site; 56 control group patients received standard care. Health professionals were alerted about any severe or life-threatening symptoms through the development of a chemotherapy symptom risk model. Patients' perceptions of ASyMS © were evaluated pre and post participation. Patients reported many benefits of using ASyMS © including improved communication with health professionals, improvements in the management of their symptoms, and feeling reassured their symptoms were being monitored while at home. ASyMS © has the potential to positively impact on the management of symptoms in patients receiving chemotherapy treatment.

Original languageEnglish
Pages (from-to)156-164
Number of pages9
JournalEuropean Journal of Cancer Care
Volume18
Issue number2
DOIs
Publication statusPublished - 31 Mar 2009

Keywords

  • cancer
  • chemotherapy
  • information technology
  • management of symptoms

Fingerprint Dive into the research topics of 'Patients' perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS ©) to monitor and manage chemotherapy related toxicity'. Together they form a unique fingerprint.

  • Cite this